Early ReportInterleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation
Introduction
Neonatal sepsis has an incidence of one to ten cases per 1000 livebirths and a high mortality rate of 15–50%.1 In very-low-birthweight infants, the incidence of sepsis is much higher: about 3% for early and 9% for late bacterial sepsis.2 Since outcome and prognosis depend on early and efficient antibiotic therapy, there is a need for sensitive and specific indicators of sepsis at the earliest stage of disease. The first clinical signs of neonatal sepsis are non-specific and laboratory indicators, such as complete blood-cell count, ratio of immature to total neutrophils,3 and C-reactive protein (CRP), do not have high sensitivity,4, 5 especially if measured early in the course of sepsis.6, 7 Isolation of causative organisms from microbiological cultures takes up to 72 h and does not identify most infected infants.8
The examination of soluble immunological mediators released minutes to hours after invasion of pathogens could dramatically improve early diagnosis of sepsis. Concentrations of the cytokines interleukin-1 receptor antagonist (IL-1ra), interleukin-6 (IL-6), and the circulating intercellular adhesion molecule-1 (cICAM-1) are raised in human sepsis.
IL-1ra is the natural receptor antagonist of the proinflammatory cytokine, IL-1β9 it reaches peak concentrations 2–4 h after experimental administration of endotoxin or IL-1β and remains raised for more than 24 h.10 Pilot studies show increased plasma concentrations of IL-1ra in adults with septic shock.11 IL-1ra concentrations are also increased in newborn babies of different gestational ages with sepsis12 or severe neonatal diseases.13
IL-6 is an important mediator of the early systemic host response to infection;14 it reaches peak concentrations rapidly after the onset of bacteriaemia, several hours before the upregulation of CRP by IL-6 begins.15 Previous studies assessed IL-6 concentrations as a marker of neonatal sepsis and reported an overall sensitivity of 80–83% and a specificity of 78–90% at the time of clinical diagnosis.16, 17, 18, 19
ICAM-1 is upregulated during inflammation and is found in the circulation in a soluble form, cICAM-1.20, 21 Two studies reported that serum and plasma concentrations of cICAM-1 were useful for early diagnosis of sepsis in 11 and 25 infants of different gestational ages with culture-positive sepsis.22, 23
Despite evidence that these inflammatory markers are upregulated at the earliest stages of experimental endotoxaemia, there is no information about the time course and prognostic power of these mediators before diagnosis of sepsis. Our aim was to examine whether IL-1ra, IL-6, and cICAM-1 could reliably predict the occurrence of sepsis at an earlier stage than the conventional marker CRP and before clinical diagnosis.
Section snippets
Study population
In a prospective multicentre study, we enrolled very-low-birthweight (<1500 g) infants admitted to six neonatal intensive-care units between December, 1994, and June, 1996. We obtained plasma samples from the infants, irrespective of presence or absence of sepsis, to measure concentrations of IL-1ra, IL-6, cICAM-1, and CRP. The specimens were collected during routine sampling for biochemical or haematological tests that were not prompted by the study. We obtained the parents' informed consent
Results
Of 336 eligible very-low-birthweight infants, 182 were enrolled in the study. 154 infants were not enrolled because no study personnel were present on admission to the intensive-care unit. 57 of the 182 infants were excluded because of transfer to non-participating hospitals, insufficient blood sampling, incomplete documentation, or because the parents refused to give consent. Thus, there were 125 infants with a complete clinical dataset: 21 in the proven-sepsis group, 20 in the no-infection
Discussion
We found that plasma concentrations of IL-1ra and IL-6 increased 2 days before clinical diagnosis of sepsis in very-low-birthweight infants. Through the use of the cytokine markers IL-1ra and IL-6, two out of three cases of sepsis could have been diagnosed 1–2 days earlier than they actually were. Furthermore, in nine of ten infants, IL-1ra and IL-6 confirmed the occurrence of sepsis on the day it was suspected. CRP concentrations increased later in the course of sepsis. CRP and cICAM-1 were
References (30)
- et al.
Early diagnosis of neonatal sepsis using a hematologic scoring system
J Pediatr
(1988) Biologic basis for interleukin-1 in disease
Blood
(1996)- et al.
Production of interleukin-1 -receptor antagonist druing experimental endotoxaemia
Lancet
(1991) - et al.
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
Blood
(1992) - et al.
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
Blood
(1990) - et al.
Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection
J Pediatr
(1996) - et al.
Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders
Lancet
(1991) - et al.
Circulating ICAM-1 in neonatal sepsis
Lancet
(1993) - et al.
Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis
J Pediatr
(1994) - et al.
Polymorphonuclear elastase in neonatal sepsis
Clin Chim Acta
(1990)
Bacterial sepsis and meningitis
Vermont-Oxford Network 1995 Database Summary
Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review
Pediatr Infect Dis J
Diagnostic audit of C-reactive protein in neonatal infection
Eur J Pediatr
The predictive value of CRP and I/T-ratio in neonatal infection
J Perinat Med
Cited by (245)
Neonatal Bacterial Sepsis and Meningitis
2023, Avery's Diseases of the NewbornNeonatal sepsis at point of care
2021, Clinica Chimica ActaInflammatory biomarkers and physiomarkers of late-onset sepsis and necrotizing enterocolitis in premature infants
2024, Frontiers in Pediatrics